Imricor Medical Systems received FDA clearances to expand its NorthStar system and Vision-MR diagnostic catheter to paediatric patients. Following the announcement, the company's share price rose ...

Echo IQ has secured firm commitments to raise approximately $110 million through an institutional share placement. The placement shares are priced at $1.45 each, representing an 8.8% discount to the ...

IREN has finalized the buyout of Ingenostrum, S.L. (Nostrum Group), establishing its first operational footprint in Europe. The transaction absorbs 490MW of secured, grid-connected power capacity in ...

Alibaba Group Holding (NYSE:BABA) has submitted a $1.5 billion proposal to acquire Chinese grocery delivery company Pupu, sparking an aggressive bidding war as part of a strategic offensive to capture ...

SpaceX has priced its initial public offering at $135 per share, raising $75 billion in the largest IPO on record and valuing the company at approximately $1.8 trillion. The Elon Musk-led company sold ...

Oracle (NYSE:ORCL) reported record fourth-quarter and full-year 2026 financial results, with broad-based growth across its Cloud Infrastructure and Cloud Applications businesses. Total Q4 revenues ...

A Los Angeles County Superior Court jury has ordered Johnson & Johnson (NYSE:JNJ) to pay $32 million to the family of a California woman who died from pleural mesothelioma, concluding that her fatal ...

Real estate firm Dexus (ASX:DXS) has stood down multiple key executives, sacked financial adviser JPMorgan, and placed its $7.3 billion infrastructure division under strategic review following a ...

Macy’s (NYSE:M) reported an increase in first-quarter profitability and sales, lifted by strong luxury performance at Bloomingdale’s and positive momentum across its core turnaround properties. The ...

Hewlett Packard Enterprise (NYSE:HPE) announced Monday its financial results for the fiscal second quarter ended April 30, 2026, delivering record-breaking top-line growth that significantly exceeded ...

AstraZeneca (NASDAQ:AZN) unveiled positive data from its late-stage EMERALD-3 clinical trial on Monday, demonstrating that adding its dual-immunotherapy regimen to standard localized therapy ...

Li Auto (NASDAQ:LI) swung to a net loss in the first quarter of 2026 as intense domestic pricing competition drastically compressed its profit margins, overshadowing a modest rise in total vehicle ...